Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)
The DOI matches its Crossref record.
Abstract
Objective: We aimed to estimate the global prevalence of type 2 diabetes over the next ten years, taking into account trends in obesity. Our analysis includes estimates for 45 countries representing almost 90% of the world population. We defined a prevalent case as anyone living with type 2 diabetes, irrespective of whether it has been formally diagnosed or not and excluded type 1 diabetes cases. Methods: We performed a global systematic search of published studies and other data sources that reported the prevalence of type 2 diabetes, as well as any factors that may change its risk or prognosis over time or between countries. Our analysis is based on critically-appraised literature and database evidence that reports the total prevalence of type 2 diabetes. From the results of this search, we appraised and selected country-specific estimates to project up to national totals. These estimates were adjusted to account for historical or future trends in risk, as well as relevant differences between countries when extrapolations were made. Our model includes country-specific obesity prevalence to incorporate the impact of obesity on diabetes trends. Results: We estimate that in 2018 there are more than 500 million prevalent cases of type 2 diabetes worldwide and the prevalence is comparable between high- and low-income countries. The prevalence will increase in all countries covered over the projection period, but the greatest growth will be experienced in lower-income countries. Disclosure: A. Bradshaw Kaiser: None. N. Zhang: None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cognitive dysfunction: a growing link between diabetes and Alzheimer’s disease
Jash, K., Gondaliya, P., Kirave, P., Kulkarni, B., Sunkaria, A., & Kalia, K. (2020) · Drug Development Research · doi:10.1002/ddr.21579 · Cited by 119
Digital coaching strategies to facilitate behavioral change in type 2 diabetes: a systematic review
Gershkowitz, B. D., Hillert, C. J., & Crotty, B. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa850 · Cited by 67
Dening, J., Islam, S. M. S., George, E., & Maddison, R. (2020) · Journal of Medical Internet Research · doi:10.2196/16437 · Cited by 50
Enricho Nkhoma, D., Jenya Soko, C., Joseph Banda, K., Greenfield, D., Li, Y.-C. (., & Iqbal, U. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100291 · Cited by 46
Son, Y., Lee, H., Son, S.-Y., Lee, C.-H., Kim, S.-Y., & Lim, Y. (2021) · Antioxidants · doi:10.3390/antiox10101546 · Cited by 35
A comparison among three maximal mathematical models of the glucose-insulin system
Pompa, M., Panunzi, S., Borri, A., & De Gaetano, A. (2021) · PLOS ONE · doi:10.1371/journal.pone.0257789 · Cited by 24
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study
Wang, J., Huang, J., Li, W., Tang, S., Sun, J., Zhang, X., Liu, J., Yi, B., Liu, J., Zhang, X., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14091 · Cited by 16
What Is the Impact of a Context-Specific Training Program for Home-Based Carers? An Evaluation Study
Bopape, M. A., Mothiba, T. M., Bastiaens, H., & Wens, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249263 · Cited by 5
Metadata
- Authors
- KAISER, A. B., ZHANG, N., & DER PLUIJM, W. V.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2018-07-01
- Volume
- 67
- Issue
- Supplement_1
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2809463321
- Cited by
- 263
- References
- 0
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.